GSK Applies in Japan for Approval of a Once-Daily, Single Inhaler Triple Therapy for COPD
First filing made for a triple therapy for chronic obstructive pulmonary disease offered in a single inhaler.
Chronic obstructive pulmonary disease (COPD) affects...

















